Calcium carbonate is used to treat heartburn and acid indigestion by neutralizing stomach acid, and it's also taken as a calcium supplement to strengthen bones and prevent osteoporosis.[1] Tums is currently being investigated across 8 indications[3], with its most advanced program in Phase 3.[1]
Tums is one of 146 small molecule programs targeting Hypocalcemia. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
107 competitors in Cystic Fibrosis
Tums
Ibsrela
Biaxin
Zyvox
Lamprene
HSK31858
Tygacil
Sirturo
ELX/TEZ/IVA
Trimethoprim-Sulfamethoxazole
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources